{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:29:11Z","timestamp":1788791351587,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.seminhematol.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T10:29:33Z","timestamp":1707992973000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic reprogramming in the CLL TME; potential for new therapeutic targets"],"prefix":"10.1053","volume":"61","author":[{"given":"Helga","family":"Simon-Molas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kabanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-6640","authenticated-orcid":false,"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.seminhematol.2024.02.001_bib0001","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the complex interplay between T cell metabolism and function","volume":"36","author":"Geltink","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","article-title":"Metabolic switching and fuel choice during T-cell differentiation and memory development","volume":"249","author":"van der Windt","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0004","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3389\/fimmu.2020.01834","article-title":"Rewiring mitochondrial metabolism for CD8(+) T cell memory formation and effective cancer immunotherapy","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.02.001_bib0005","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41590-018-0156-5","article-title":"Second signals rescue B cells from activation-induced mitochondrial dysfunction and death","volume":"19","author":"Akkaya","year":"2018","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.02.001_bib0006","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","article-title":"Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling","volume":"5","author":"Waters","year":"2018","journal-title":"iScience"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0008","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","article-title":"Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis","volume":"21","author":"Weisel","year":"2020","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.02.001_bib0009","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","article-title":"B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis","volume":"29","author":"Muri","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","article-title":"Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells","volume":"45","author":"Lam","year":"2016","journal-title":"Immunity"},{"issue":"3215","key":"10.1053\/j.seminhematol.2024.02.001_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0012","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"7858","key":"10.1053\/j.seminhematol.2024.02.001_bib0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.02.001_bib0014","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.02.001_bib0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood.2020008608","article-title":"Venetoclax and ibrutinib for patients with relapsed\/refractory chronic lymphocytic leukemia","volume":"137","author":"Niemann","year":"2021","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminhematol.2024.02.001_bib0016","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa2213093","article-title":"First-line venetoclax combinations in chronic lymphocytic leukemia","volume":"388","author":"Eichhorst","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0017","first-page":"755","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"JClinInvest"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.02.001_bib0018","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1158\/0008-5472.CAN-08-2325","article-title":"In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow","volume":"68","author":"Rv","year":"2008","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0019","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.02.001_bib0020","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.2020005964","article-title":"TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target","volume":"137","author":"Kennedy","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0021","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s41375-023-01898-w","article-title":"Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation","volume":"37","author":"Kielbassa","year":"2023","journal-title":"Leukemia"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.02.001_bib0022","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3324\/haematol.2020.268037","article-title":"Targeting the tumor microenvironment in chronic lymphocytic leukemia","volume":"106","author":"Svanberg","year":"2021","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.02.001_bib0023","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.4049\/jimmunol.1402304","article-title":"Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase delta but not SYK or BTK in chronic lymphocytic leukemia cells","volume":"194","author":"Till","year":"2015","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0024","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","article-title":"Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies","volume":"36","author":"Gui\u00e8ze","year":"2019","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.02.001_bib0025","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1182\/blood.2021014304","article-title":"Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies","volume":"140","author":"Thomalla","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0026","unstructured":"Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: how much do we actually know?, (2019)."},{"issue":"22","key":"10.1053\/j.seminhematol.2024.02.001_bib0027","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Jitschin","year":"2015","journal-title":"Blood"},{"issue":"38","key":"10.1053\/j.seminhematol.2024.02.001_bib0028","doi-asserted-by":"crossref","first-page":"24980","DOI":"10.18632\/oncotarget.25166","article-title":"Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells","volume":"9","author":"Vangapandu","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1161254","article-title":"Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia","volume":"13","author":"Timofeeva","year":"2023","journal-title":"Front Oncol"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.02.001_bib0031","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","article-title":"Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition","volume":"126","author":"Jacque","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.02.001_bib0032","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/10428194.2018.1509317","article-title":"Oxidative stress in chronic lymphocytic leukemia: still a matter of debate","volume":"60","author":"D'Arena","year":"2019","journal-title":"Leuk Lymphom"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.02.001_bib0033","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, Lipids and Proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2023.06.030","article-title":"Oxygen-consumption based quantification of chemogenetic H(2)O(2) production in live human cells","volume":"206","author":"den Toom","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0035","article-title":"Mitochondrial H2O2 release does not directly cause genomic DNA damage","author":"DMKv","year":"2023","journal-title":"bioRxiv"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0036","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0037","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0038","first-page":"56","article-title":"The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia","volume":"91","author":"van't Veer","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.02.001_bib0039","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2004-08-3344","article-title":"The LPL\/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia","volume":"106","author":"Oppezzo","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.02.001_bib0040","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","article-title":"High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia","volume":"19","author":"Heintel","year":"2005","journal-title":"Leukemia"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.02.001_bib0041","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3390\/molecules22122083","article-title":"Lipoprotein Lipase Expression in Chronic lymphocytic leukemia: new insights into leukemic progression","volume":"22","author":"Prieto","year":"2017","journal-title":"Molecules"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0042","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.leu.2405058","article-title":"Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells","volume":"22","author":"Pallasch","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0043","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.leukres.2009.07.032","article-title":"Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity","volume":"34","author":"Mansouri","year":"2010","journal-title":"Leuk Res"},{"issue":"1-2","key":"10.1053\/j.seminhematol.2024.02.001_bib0044","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbalip.2004.08.015","article-title":"Lipoprotein lipase-dependent binding and uptake of low density lipoproteins by THP-1 monocytes and macrophages: possible involvement of lipid rafts","volume":"1686","author":"Makoveichuk","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.02.001_bib0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/metabo13070799","article-title":"The role of cholesterol in chronic lymphocytic leukemia development and pathogenesis","volume":"13","author":"White","year":"2023","journal-title":"Metabolites"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.02.001_bib0046","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0047","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2011-07-370403","article-title":"Surface IgM stimulation induces MEK1\/2-dependent MYC expression in chronic lymphocytic leukemia cells","volume":"119","author":"Krysov","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.02.001_bib0048","doi-asserted-by":"crossref","first-page":"e60275","DOI":"10.1371\/journal.pone.0060275","article-title":"CLL cells respond to B-Cell receptor stimulation with a microRNA\/mRNA signature associated with MYC activation and cell cycle progression","volume":"8","author":"Pede","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.02.001_bib0049","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2015-07-660969","article-title":"Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation","volume":"127","author":"Yeomans","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-022-00292-z","article-title":"Targeting metabolic reprogramming in chronic lymphocytic leukemia","volume":"11","author":"Nie","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0051","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a p53-inducible regulator of glycolysis and apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.02.001_bib0052","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cmet.2013.06.019","article-title":"Metabolic regulation by p53 family members","volume":"18","author":"Berkers","year":"2013","journal-title":"Cell Metab"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0053","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbcan.2018.06.001","article-title":"Control of metabolism by p53 - Cancer and beyond","volume":"1870","author":"Labuschagne","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0054","series-title":"Glutamine deprivation induces p53-Independent cell death in B-Cell malignancies","author":"Montironi","year":"2024"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41408-017-0039-2","article-title":"Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition","volume":"8","author":"Galicia-Vazquez","year":"2018","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0056","first-page":"151","article-title":"Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia","volume":"109","author":"Chen","year":"2024","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.02.001_bib0057","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.02.001_bib0058","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14728222.2018.1451840","article-title":"Notch signaling as a therapeutic target for acute lymphoblastic leukemia","volume":"22","author":"Bellavia","year":"2018","journal-title":"Expert Opin Ther Targets"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.02.001_bib0059","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/leu.2017.90","article-title":"NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components","volume":"31","author":"Pozzo","year":"2017","journal-title":"Leukemia"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.02.001_bib0060","doi-asserted-by":"crossref","first-page":"E2911","DOI":"10.1073\/pnas.1702564114","article-title":"Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia","volume":"114","author":"Fabbri","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.02.001_bib0061","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/leu.2013.319","article-title":"Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia","volume":"28","author":"Arruga","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.02.001_bib0062","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0063","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0064","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12967-020-02667-4","article-title":"Hypoxia and the phenomenon of immune exclusion","volume":"19","author":"Pietrobon","year":"2021","journal-title":"J Transl Med"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fonc.2016.00041","article-title":"Hypoxia and hypoxia-inducible factors in leukemias","volume":"6","author":"Deynoux","year":"2016","journal-title":"Front Oncol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.02.001_bib0066","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/1541-7786.MCR-14-0028","article-title":"The role of hypoxia and exploitation of the hypoxic environment in hematologic malignancies","volume":"12","author":"Muz","year":"2014","journal-title":"Mol Cancer Res"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.02.001_bib0067","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1182\/blood-2008-10-185686","article-title":"Aberrant regulation of pVHL levels by microRNA promotes the HIF\/VEGF axis in CLL B cells","volume":"113","author":"Ghosh","year":"2009","journal-title":"Blood"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.02.001_bib0068","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2015-07-657056","article-title":"HIF-1alpha regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment","volume":"127","author":"Valsecchi","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0069","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/bloodadvances.2016000984","article-title":"Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment","volume":"1","author":"Serra","year":"2016","journal-title":"Blood Adv"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.02.001_bib0070","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1182\/bloodadvances.2023010305","article-title":"T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia","volume":"7","author":"Montironi","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.02.001_bib0071","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00277-012-1425-2","article-title":"Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia","volume":"91","author":"Perry","year":"2012","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0072","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.2021013990","article-title":"Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment","volume":"140","author":"Chen","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.02.001_bib0073","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0074","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fchem.2014.00061","article-title":"Membrane transporters for the special amino acid glutamine: structure\/function relationships and relevance to human health","volume":"2","author":"Pochini","year":"2014","journal-title":"Front Chem"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.02.001_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm.4464","article-title":"Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models","volume":"24","author":"Schulte","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.02.001_bib0076","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1479-7364-3-2-195","article-title":"Analysis and update of the human solute carrier (SLC) gene superfamily","volume":"3","author":"He","year":"2009","journal-title":"Hum Genomics"},{"issue":"17","key":"10.1053\/j.seminhematol.2024.02.001_bib0077","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.3390\/ijms21176156","article-title":"Amino acid transporters as targets for cancer therapy: why, where, when, and how","volume":"21","author":"Broer","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.02.001_bib0078","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer","volume":"35","author":"van Geldermalsen","year":"2016","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0079","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2018.07.007","article-title":"The role of ASCT2 in cancer: a review","volume":"837","author":"Liu","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.02.001_bib0080","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","article-title":"Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia","volume":"122","author":"Willems","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.02.001_bib0081","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0082","unstructured":"Glutamine addiction: a new therapeutic target in cancer, (2010)."},{"issue":"5","key":"10.1053\/j.seminhematol.2024.02.001_bib0083","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acsmedchemlett.6b00060","article-title":"Allosteric glutaminase inhibitors based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold","volume":"7","author":"Zimmermann","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0084","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bmcl.2015.12.031","article-title":"2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: a novel scaffold for inhibition of ASCT2-mediated glutamine transport","volume":"26","author":"Schulte","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0085","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/1878-0261.13364","article-title":"JAK-STAT signalling shapes the NF-kappaB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL","volume":"17","author":"Haselager","year":"2023","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0086","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0087","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-017-02329-y","article-title":"The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy","volume":"8","author":"Landau","year":"2017","journal-title":"Nat Commun"},{"issue":"7698","key":"10.1053\/j.seminhematol.2024.02.001_bib0088","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nature26140","article-title":"The protein histidine phosphatase LHPP is a tumour suppressor","volume":"555","author":"Hindupur","year":"2018","journal-title":"Nature"},{"issue":"15","key":"10.1053\/j.seminhematol.2024.02.001_bib0089","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.02.001_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.leu.2403271","article-title":"Nucleoside transporters in chronic lymphocytic leukaemia","volume":"18","author":"Pastor-Anglada","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0091","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s42003-020-1027-9","article-title":"Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations","volume":"3","author":"Ahl","year":"2020","journal-title":"Commun Biol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.02.001_bib0092","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41587-020-0651-8","article-title":"Single-cell metabolic profiling of human cytotoxic T cells","volume":"39","author":"Hartmann","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.02.001_bib0093","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cmet.2020.09.013","article-title":"Immunometabolism in the single-cell era","volume":"32","author":"Artyomov","year":"2020","journal-title":"Cell Metab"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.02.001_bib0094","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","article-title":"SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution","volume":"32","author":"Arguello","year":"2020","journal-title":"Cell Metab"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0095","article-title":"In-depth immunometabolic profiling by measuring single-cell protein translation inhibition via bioorthogonal noncanonical amino acid tagging (SCENITH-BONCAT)","author":"Vrieling","year":"2023","journal-title":"bioRxiv"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.02.001_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112828","article-title":"QUAS-R: an SLC1A5-mediated glutamine uptake assay with single-cell resolution reveals metabolic heterogeneity with immune populations","volume":"42","author":"Pelgrom","year":"2023","journal-title":"Cell Rep"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.02.001_bib0097","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/ijms22052376","article-title":"RGDS-modified superporous Poly(2-Hydroxyethyl Methacrylate)-based scaffolds as 3d in vitro leukemia model","volume":"22","author":"Svozilova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminhematol.2024.02.001_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639572","article-title":"3D bioprinting allows the establishment of long-term 3D culture model for chronic lymphocytic leukemia cells","volume":"12","author":"Sbrana","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.02.001_bib0099","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1097\/HS9.0000000000000938","article-title":"In Vitro 3D spheroid culture system displays sustained T cell-dependent CLL proliferation and survival","volume":"7","author":"Haselager","year":"2023","journal-title":"Hemasphere"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.02.001_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41467-022-34642-6","article-title":"Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis","volume":"14","author":"Broseus","year":"2023","journal-title":"Nat Commun"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:19:50Z","timestamp":1720531190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0037196324000167"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.02.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in the CLL TME; potential for new therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}